Camp4 Therapeutics (CAMP) Equity Ratio (2023 - 2025)
Camp4 Therapeutics (CAMP) has disclosed Equity Ratio for 3 consecutive years, with 0.4 as the latest value for Q4 2025.
- Quarterly Equity Ratio fell 49.78% to 0.4 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.4 through Dec 2025, down 49.78% year-over-year, with the annual reading at 0.4 for FY2025, 49.78% down from the prior year.
- Equity Ratio hit 0.4 in Q4 2025 for Camp4 Therapeutics, down from 0.68 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.82 in Q1 2025 to a low of 7.44 in Q3 2024.
- Historically, Equity Ratio has averaged 0.89 across 3 years, with a median of 0.68 in 2025.
- Biggest five-year swings in Equity Ratio: surged 135.81% in 2024 and later tumbled 49.78% in 2025.
- Year by year, Equity Ratio stood at 2.25 in 2023, then soared by 135.81% to 0.81 in 2024, then crashed by 49.78% to 0.4 in 2025.
- Business Quant data shows Equity Ratio for CAMP at 0.4 in Q4 2025, 0.68 in Q3 2025, and 0.78 in Q2 2025.